• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏性猝死的风险分层影像学评估。

Imaging for risk stratification of sudden cardiac death.

机构信息

Department of Cardiology, Heart Lung Centre, Leiden University Medical Centre, Albinusdreef 2, 2300, RC, Leiden, The Netherlands.

Turku Heart Centre, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, FI-20520, Turku, Finland.

出版信息

Herzschrittmacherther Elektrophysiol. 2022 Sep;33(3):261-267. doi: 10.1007/s00399-022-00884-6. Epub 2022 Jul 16.

DOI:10.1007/s00399-022-00884-6
PMID:35841401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9411093/
Abstract

Sudden cardiac death (SCD) can be effectively prevented with the use of implantable cardioverter-defibrillator (ICD). Current guidelines advocate an ICD for primary prevention in the presence of an left ventricular ejection fraction (LVEF) ≤ 35%. The majority of individuals that experience SCD, however, have an LVEF > 35%. Multimodality cardiac imaging has the ability to visualize the three factors responsible for arrhythmia-mediated SCD, namely substrate, trigger and modulator. Advances in cardiac imaging techniques have allowed improved SCD risk stratification, especially in the group of patients with an LVEF > 35%. However, clinical integration of cardiac imaging for SCD risk stratification will require more comparative data between modalities and parameters, as well as evidence of an impact on outcomes. The current review represents an update on the use of multimodality imaging techniques for SCD risk stratification.

摘要

心脏性猝死 (SCD) 可以通过植入式心脏复律除颤器 (ICD) 的使用得到有效预防。目前的指南主张在左心室射血分数 (LVEF) ≤ 35% 的情况下将 ICD 用于一级预防。然而,大多数经历 SCD 的人 LVEF > 35%。多模态心脏成像能够可视化导致心律失常介导的 SCD 的三个因素,即基质、触发和调节剂。心脏成像技术的进步使 SCD 风险分层得到了改善,特别是在 LVEF > 35%的患者群体中。然而,心脏成像用于 SCD 风险分层的临床整合将需要更多模态和参数之间的比较数据,以及对结果产生影响的证据。本综述代表了多模态成像技术在 SCD 风险分层中的应用的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c5/9411093/9228c00bd259/399_2022_884_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c5/9411093/58690199bcde/399_2022_884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c5/9411093/496ecc668697/399_2022_884_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c5/9411093/9228c00bd259/399_2022_884_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c5/9411093/58690199bcde/399_2022_884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c5/9411093/496ecc668697/399_2022_884_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c5/9411093/9228c00bd259/399_2022_884_Fig3_HTML.jpg

相似文献

1
Imaging for risk stratification of sudden cardiac death.心脏性猝死的风险分层影像学评估。
Herzschrittmacherther Elektrophysiol. 2022 Sep;33(3):261-267. doi: 10.1007/s00399-022-00884-6. Epub 2022 Jul 16.
2
Imaging for sudden cardiac death risk stratification: Current perspective and future directions.用于心源性猝死风险分层的影像学检查:当前的观点和未来方向。
Prog Cardiovasc Dis. 2019 May-Jun;62(3):205-211. doi: 10.1016/j.pcad.2019.04.005. Epub 2019 May 2.
3
Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.磁共振成像显示的心脏性猝死基质:从研究工具到临床应用
Circ Cardiovasc Imaging. 2017 Jul;10(7). doi: 10.1161/CIRCIMAGING.116.005461.
4
Risk Stratification for Sudden Cardiac Death After Myocardial Infarction.心肌梗死后心源性猝死的风险分层。
Annu Rev Med. 2018 Jan 29;69:147-164. doi: 10.1146/annurev-med-041316-090046.
5
Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?心肌梗死后的风险分层:左心室射血分数是否足以预防心源性猝死?
Eur Heart J. 2013 Jul;34(26):1964-71. doi: 10.1093/eurheartj/eht109. Epub 2013 May 3.
6
[Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].[微伏级T波交替试验阴性结果有助于安排左心室收缩功能障碍患者心脏性猝死一级预防中植入心脏复律除颤器的顺序]
Pol Merkur Lekarski. 2012 Oct;33(196):193-7.
7
CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.基于 CMR 的非缺血性心肌病患者心源性猝死风险分层与植入式心脏复律除颤器的应用。
Int J Mol Sci. 2021 Jul 1;22(13):7115. doi: 10.3390/ijms22137115.
8
Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction.基于心律失常风险分层和左心室逆重构预测的非缺血性扩张型心肌病患者的一级预防植入型心律转复除颤器的应用。
Heart Fail Rev. 2023 Jan;28(1):229-240. doi: 10.1007/s10741-022-10246-6. Epub 2022 May 19.
9
Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy.射血分数之外:扩张型心肌病患者心脏性猝死风险分层的新临床方法。
Curr Cardiol Rev. 2022;18(2):e040821195265. doi: 10.2174/1573403X17666210804125939.
10
Cardiac magnetic resonance imaging and primary prevention implantable cardioverter defibrillator therapy: current recommendations and future directions.心脏磁共振成像与植入式心脏复律除颤器在一级预防中的应用:当前的建议和未来的方向。
J Cardiovasc Med (Hagerstown). 2018 May;19(5):223-228. doi: 10.2459/JCM.0000000000000650.

本文引用的文献

1
Recent Progress in Models for Atherosclerosis Studies.动脉粥样硬化研究模型的最新进展
Front Cardiovasc Med. 2022 Jan 27;8:790529. doi: 10.3389/fcvm.2021.790529. eCollection 2021.
2
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
3
Ring-like late gadolinium enhancement for predicting ventricular tachyarrhythmias in non-ischaemic dilated cardiomyopathy.
环形晚期钆增强预测非缺血性扩张型心肌病室性心动过速/颤动。
Eur Heart J Cardiovasc Imaging. 2021 Sep 20;22(10):1130-1138. doi: 10.1093/ehjci/jeab117.
4
Myocardial Substrate Characterization by CMR T Mapping in Patients With NICM and No LGE Undergoing Catheter Ablation of VT.非缺血性心肌病且无延迟强化的室性心动过速患者行导管消融时通过心脏磁共振T成像对心肌底物进行特征分析
JACC Clin Electrophysiol. 2021 Jul;7(7):831-840. doi: 10.1016/j.jacep.2020.10.002. Epub 2021 Jan 27.
5
Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.基于心脏磁共振 T1 mapping 测量长、短 T1 值的心肌细胞外容积分数评价对肥厚型心肌病的预后价值。
Eur Radiol. 2021 Jul;31(7):4557-4567. doi: 10.1007/s00330-020-07650-7. Epub 2021 Jan 15.
6
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 年美国心脏病学会/美国心脏协会肥厚型心肌病诊断和治疗指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.
7
T Mapping Tissue Heterogeneity Provides Improved Risk Stratification for ICDs Without Needing Gadolinium in Patients With Dilated Cardiomyopathy.T 映射组织异质性为扩张型心肌病患者提供了无需钆增强的 ICD 风险分层改善。
JACC Cardiovasc Imaging. 2020 Sep;13(9):1917-1930. doi: 10.1016/j.jcmg.2020.03.014. Epub 2020 Jul 9.
8
Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.肥厚型心肌病伴左心室收缩功能障碍患者的结局。
J Am Coll Cardiol. 2020 Jun 23;75(24):3033-3043. doi: 10.1016/j.jacc.2020.04.045.
9
Relationship between left ventricular dyssynchrony and scar burden in the genesis of ventricular tachyarrhythmia.左心室失同步与瘢痕负荷在室性心律失常发生中的关系。
J Nucl Cardiol. 2018 Apr;25(2):555-569. doi: 10.1007/s12350-017-1095-5. Epub 2017 Nov 6.
10
Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy.整体纵向应变和左心房容积指数对肥厚型心肌病患者具有递增的预后价值。
Circ Cardiovasc Imaging. 2017 Jul;10(7). doi: 10.1161/CIRCIMAGING.116.005706.